17.7 C
New York
Wednesday, June 17, 2026

Tag: supplement

newssourceFORcompanyinformationcontent1marketreleases

Sun Communities Reports Results for the Second Quarter and First Six Months of 2025

Net Income per Diluted Share of $10.02 for the Quarter, inclusive of Income from Discontinued Operations

Extra Space Storage Inc. Reports 2025 Second Quarter Results

SALT LAKE CITY, July 30, 2025 /PRNewswire/ -- Extra Space Storage Inc. (NYSE: EXR) (the "Company"), a leading owner and operator of self-storage facilities...

eBay Inc. Reports Second Quarter 2025 Results

Revenue of $2.7 billion, up 6% on an as-reported basis and up 4% on an FX-Neutral basisGross Merchandise Volume ("GMV") of $19.5 billion, up...

Alkami Announces Second Quarter 2025 Financial Results

PLANO, Texas, July 30, 2025 /PRNewswire/ -- Alkami Technology, Inc. (Nasdaq: ALKT) ("Alkami" or "the Company"), a leading cloud-based digital banking solutions provider for...

Virtu Announces Second Quarter 2025 Results

NEW YORK, July 30, 2025 (GLOBE NEWSWIRE) -- Virtu Financial, Inc. (NYSE: VIRT), a leading provider of financial services and products that leverages cutting edge technology to deliver innovative, transparent trading solutions to its clients and liquidity to the global markets, today reported results for the second quarter ended June 30, 2025.

747 Media House Helps Cannabis Brands Like ‘BudWell’ Drive Revenue with SEO Excellence

747 Media House leads cannabis SEO and dispensary marketing in 2025. Understand why it's the top-rated cannabis marketing agency driving revenue and compliance. 
747 Media House leads cannabis SEO and dispensary marketing in 2025. Understand why it's the top-rated cannabis marketing agency driving revenue and compliance.

Men Across the U.S. Turn to Natural Testosterone Support: Blue Ribbon LLC Highlights Effective Wellness Formula

Blue Ribbon LLC features a natural supplement formulated with key nutrients to help support men’s vitality, energy, and healthy testosterone levels.

Larimar Therapeutics Announces Pricing of Underwritten Public Offering

BALA CYNWYD, Pa., July 29, 2025 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced the pricing of its previously announced underwritten public offering of 18,750,000 shares of its common stock at a price to the public of $3.20 per share. The aggregate gross proceeds to Larimar from this offering are expected to be $60.0 million, before deducting underwriting discounts and commissions and other offering expenses. In addition, Larimar has granted the underwriters a 30-day option to purchase up to an additional 2,812,500 shares of its common stock at the public offering price, less underwriting discounts and commissions. All shares of common stock are being offered by Larimar. The offering is expected to close on or about July 31, 2025, subject to the satisfaction of customary closing conditions.

SlumberSlim Launches Sleep-Centric Formula to Support Metabolic Balance and Circadian Health in Adults Over 35

New Non-Stimulant Supplement Aims to Complement Overnight Wellness Routines with Polyamine-Aligned Botanical Support 
New Non-Stimulant Supplement Aims to Complement Overnight Wellness Routines with Polyamine-Aligned Botanical Support

LipoVive Releases Ingredient Report Comparing Natural GLP-1 Support to Synthetic Drugs Like Mounjaro

A Plant-Based Formula With Science-Referenced Compounds Designed to Support Hormonal Weight Balance Without Prescription Medications 
A Plant-Based Formula With Science-Referenced Compounds Designed to Support Hormonal Weight Balance Without Prescription Medications

TETRA TECHNOLOGIES, INC. ANNOUNCES STRONG SECOND QUARTER 2025 RESULTS AND PROVIDES FULL YEAR GUIDANCE

Second Quarter 2025 Financial Highlights Revenue of $174 million increased 11% sequentiallyNet income before taxes of $19.4 million increased $14.4 million sequentiallyAdjusted EBITDA of $35.9...

Regency Centers Reports Second Quarter 2025 Results

JACKSONVILLE, Fla., July 29, 2025 (GLOBE NEWSWIRE) -- Regency Centers Corporation (“Regency Centers,” “Regency” or the “Company”) (Nasdaq: REG) today reported financial and operating results for the quarterly period ended June 30, 2025, and provided updated 2025 earnings guidance. For the three months ended June 30, 2025 and 2024, Net Income Attributable to Common Shareholders was $0.56 per diluted share, and $0.54 per diluted share, respectively.

Life Time Launches Complimentary AI Health Companion for Everyone: “Just Ask L•AI•C”

Life Time's L•AI•C generates personalized workouts, nutrition and supplement recommendations and recovery tips with decades of health and wellness content CHANHASSEN, Minn., July 29,...

American Assets Trust, Inc. Reports Second Quarter 2025 Financial Results

Net income available to common stockholders of $5.5 million and $48.0 million for the three and six months ended June 30, 2025, respectively, or $0.09 and $0.79 per diluted share, respectively.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsSupplement

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers